Live Webinar on Pregnancy and Lactation in Multiple Sclerosis

Pregnancy and lactation in multiple sclerosis (MS) remain critical and often complex phases in a woman’s disease journey. Questions around relapse risk, treatment interruption, breastfeeding safety, and long-term outcomes require careful, individualized decision-making. With evolving evidence and updated recommendations, clinicians must balance disease control with maternal and infant safety.

In this live webinar, Celia Oreja-Guevara and Melinda Magyari will discuss practical, real-world approaches to managing MS before, during, and after pregnancy.

Key Highlights

• A clear overview of relapse risk and disease activity during pregnancy and the postpartum period.
• Guidance on treatment planning before conception and strategies around treatment interruption or continuation.
• Practical considerations for improving patient experience and long-term outcomes.
• Live Q&A to address your clinical questions

Register to access the webinar

This session will be held live on Zoom. We warmly encourage you to register in advance to secure your place and take part in the exchange of knowledge and discussions.

Language

The session will be held in English with translated auto-captions into many languages, offered by Zoom platform.

This webinar might interest you if you are:

• Neurologists with a particular interest in multiple sclerosis therapies and treatments
• Neurologists in training
• Nurses engaged in the care of patients with multiple sclerosis
• Patient representatives

Questions and discussion

If there are specific questions you would like to see addressed during the session, we encourage you to share them in advance at learning@paradigms.foundation. This will allow the speakers to incorporate them into their presentations.

You will also have the opportunity to raise questions directly and actively contribute to the discussion during the webinar and the dedicated Q&A session.

Technology used

The session will be conducted via Zoom, with access credentials shared upon completion of your registration.

Time and date

The session will be held in English on Tuesday, 10th March 2026 from 16:30 to 17:30 CET.

Invited Speakers

Celia Oreja-Guevara

Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid

After receiving her MD from the University Complutense, Madrid, Professor Oreja-Guevara completed a PhD in neuroimmunology at the Max-Planck-Institute for Neurobiology, University of Munich, Munich (Germany). She then went on to complete a residency in the Department of Neurology at the University of Bochum, Bochum (Germany) and a postdoctoral fellowship in neuroimaging at the University Hospital San Raffaele, Milan (Italy). She has also held posts at the University of Düsseldorf (Germany),Hospital de Fuenlabrada and at the University Hospital La Paz, both in Madrid.

Professor Oreja-Guevara’s research interests centre on family planning, menopause, clinical and neuroimaging correlations in MS and the use of optical coherence tomography. As an investigator, she has participated in a number of MS clinical trials and currently heads Paradigms, an independent and non-profit international group of Multiple Sclerosis experts. Currently, Professor Oreja-Guevara is an expert for the Spanish Medicines Agency and for the Scientific Advisory Group on Neurology of the European Medicines Agency.

Melinda Magyari

Director of the Danish Multiple Sclerosis Registry and Consultant neurologist at department of Neurology, Rigshospitalet, Denmark

Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved in pharmacoepidemiological studies investigating the effectiveness and long-term safety of disease modifying therapies.

Funding

This webinar is organized with the financial support of Roche. Roche has not been involved in the elaboration of the presentations.